Semaglutide

Semaglutide

Sequence:
H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
CAS NO.: 910463-68-2
Molecular Formula: C187H291N45O59
Molecular Weight: 4,113.64
Appearance:White Crystalline Powder
Purity: 99.38%
Identification: Infrared Absorption
Loss On Drying: ≤0.2%
Residue On Ignition: ≤0.3%
Chloride:≤0.05%
Sulfate:≤0.03%
Heavy Metals:≤0.0015%
Application:
1. Used as both injection-type or oral-type drug.
2. Used for the treatment of obesity.
3. Improve cardiovascular function
4. Treatment of type 2 diabetes in adults
About Semaglutide:
Semaglutide(Ozempic) is a glucagon-like peptide-1 analogue for once-weekly subcutaneous treatment of type 2 diabetes.Semaglutide is a pharmaceutical drug which is used for the treatment of type 2 diabetes. Semaglutide has demonstrated the potential to improve the treatment of type 2 diabetes and the positive recommendation from the Advisory Committee marks an important step towards making semaglutide available to adults with type 2 diabetes in the US. Semaglutide(Ozempic), a newly once-weekly glucagon like peptide-1 (GLP-1) receptor agonist, has showed a favorable effect on glycaemic control and weight reduction in type 2 diabetes mellitus (T2DM). 
In humans semaglutide is chemically similar to glucagon-like peptide-1 (GLP-1).
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog and functions as a GLP-1 agonist.
Furthermore, semaglutide demonstrated a significant, beneficial effect on cardiovascular outcomes and a safety profile similar to that of other GLP-1 receptor agonists.Semaglutide also improves cardiovascular function, reduces the risk of stroke by 39%, and reduces the risk of myocardial infarction by 26%.

 

 

Please feel free to contact usfor: the product Quotation (the product price),COA (Certificate of Analysis),New Sales Promotion,New Products,And any other assistance.

For more information of product, please send the email to bkherb@globals-globals.com

Bolise Co., Limited.

Bolise Co., Limited.After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.This form is unable to receive your inquiry from aol, hotmail, gmail or others but company email address.

E-MAIL:bkherb@globals-globals.com
TEL: +86 592 536 5868
WHATSAPP: +86 189 6516 2351